Vol 80, No 1 (2022)
Editorial
Published online: 2022-01-04
Coronary sinus Reducer: An adjunctive tool for the treatment of patients with chronic total occlusion of the right coronary artery
Abstract
Not available
References
- GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 . Lancet. 2016; 388(10053): 1459–1544.
- Crea F, Merz CB, Beltrame J, et al. Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization. Eur Heart J. 2019; 40(29): 2455–2462.
- Abdallah MS, Wang K, Magnuson EA, et al. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease. J Am Coll Cardiol. 2017; 69(16): 2039–2050.
- Konigstein M, Giannini F, Banai S. The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives. European Heart Journal. 2017; 39(11): 925–933.
- Verheye S, Agostoni P, Giannini F, et al. Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study). EuroIntervention. 2021; 17(7): 561–568.
- Ponticelli F, Khokhar A, Leenders G, et al. Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study. International Journal of Cardiology. 2021; 337: 29–37.
- Verheye S, Jolicœur E, Behan M, et al. Efficacy of a device to narrow the coronary sinus in refractory angina . N Engl J Med. 2015; 372(6): 519–527.
- Zivelonghi C, Verheye S, Timmers L, et al. Efficacy of coronary sinus reducer in patients with non-revascularized chronic total occlusions. Am J Cardiol. 2020; 126: 1–7.
- Mrak M, Pavšič N, Ponticelli F, et al. Efficacy of coronary sinus reducer implantation in patients with chronic total occlusion of the right coronary artery. Kardiol Pol. 2022; 80(1): XXX–XXX.
- Maria GDe, Alkhalil M, Borlotti A, et al. Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: the Oxford Acute Myocardial Infarction – Pressure-controlled Intermittent Coronary Sinus Occlusion study (OxAMI-PICSO study). EuroIntervention. 2018; 14(3): e352–e359.
